Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Phase 2 clinical study for Alzheimer disease completed
March 17th, 2005
Voyager Pharmaceutical Corp., a biopharmaceutical company focused on diseases of aging and development, announced the completion of its 48-week phase 2 Alzheimer disease study. The double blind, placebo controlled multi-center trial enrolled 109 female Alzheimer disease patients in 2003. Voyager expects to receive the results of the double blind study soon. Interim data from approximately 40 subjects in Voyager's complementary phase 2 study in men will be available soon thereafter. Voyager plans to present the findings from these 2 studies, along with the bioavailability data from human trials using its patented implant, to the U.S. Food and Drug Administration (FDA) in...
Source: Women's Health Weekly (2005-03-17)
|
